The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/12959
StudyName: Eligibility Breast Cancer NCT00033514
Date of export from the portal: 02.07.2020
Date of Upload / last change: 07.01.2016
License: Creative Commons BY 4.0

----

Description: 
Trastuzumab and Erlotinib as First-Line Therapy in Treating Women With Metastatic Breast Cancer Associated With HER2/Neu Overexpression; ODM derived from: https://clinicaltrials.gov/show/NCT00033514
